Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Experimental Hematology
|
February 1, 1993
Suppression of normal human hematopoiesis by cytomegalovirus in vitro
F R MacKintosh, J Adlish, S W Hall, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1979
Kinetics of gallium nitrate, a new anticancer agent
S W Hall, K Yeung, R S Benjamin, et al.
Cancer Investigation
|
March 26, 1998
Efficacy of intravenous granisetron to control nausea and vomiting during multiple cycles of cisplatin-based chemotherapy
H L Ritter, R J Gralla, S W Hall, et al.
Advances in Alcohol & Substance Abuse
|
January 1, 1989
Pragmatic procedures for detecting and documenting alcoholism in medical patients
N G Hoffmann, P A Harrison, S W Hall, et al.
Cancer Research
|
November 1, 1978
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative
S S Legha, J U Gutterman, S W Hall, et al.
Circulation
|
January 1, 1977
Hypereosinophilic syndrome with biventricular involvement
S W Hall, A Theologides, A H From, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1978
Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolate
S W Hall, T F Tenczynski, R S Benjamin, et al.
Journal of Clinical Pharmacology
|
May 1, 1978
Clinica, pharmacology of tetrahydrouridine
D H Ho, G P Bodey, S W Hall, et al.
Cancer Treatment Reports
|
March 1, 1976
A pharmacokinetically based phase I-II study of single-dose actinomycin D (NSC-3053)
R S Benjamin, S W Hall, M A Burgess, et al.
Cancer Clinical Trials
|
January 1, 1980
Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma
S S Legha, S W Hall, K C Powell, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Experimental Hematology
|
February 1, 1993
Suppression of normal human hematopoiesis by cytomegalovirus in vitro
F R MacKintosh, J Adlish, S W Hall, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1979
Kinetics of gallium nitrate, a new anticancer agent
S W Hall, K Yeung, R S Benjamin, et al.
Cancer Investigation
|
March 26, 1998
Efficacy of intravenous granisetron to control nausea and vomiting during multiple cycles of cisplatin-based chemotherapy
H L Ritter, R J Gralla, S W Hall, et al.
Advances in Alcohol & Substance Abuse
|
January 1, 1989
Pragmatic procedures for detecting and documenting alcoholism in medical patients
N G Hoffmann, P A Harrison, S W Hall, et al.
Cancer Research
|
November 1, 1978
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative
S S Legha, J U Gutterman, S W Hall, et al.
Circulation
|
January 1, 1977
Hypereosinophilic syndrome with biventricular involvement
S W Hall, A Theologides, A H From, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1978
Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolate
S W Hall, T F Tenczynski, R S Benjamin, et al.
Journal of Clinical Pharmacology
|
May 1, 1978
Clinica, pharmacology of tetrahydrouridine
D H Ho, G P Bodey, S W Hall, et al.
Cancer Treatment Reports
|
March 1, 1976
A pharmacokinetically based phase I-II study of single-dose actinomycin D (NSC-3053)
R S Benjamin, S W Hall, M A Burgess, et al.
Cancer Clinical Trials
|
January 1, 1980
Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma
S S Legha, S W Hall, K C Powell, et al.
Page
of 7